AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments
Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong demand for its cancer and rare diseases medicines, after third-quarter results beat estimates.
Spotify's Q3 Profit Quadruples
AstraZeneca's Q3 sales rose 18% YoY to $13.6 billion Adjusted EPADS hit $1.04, exceeding expectations. U.S. investment of ...
Revenue grew by 55% year over year to $104.8 million, landing near the top of management's guidance range. Operating losses ...
Hosted on MSN21h
AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat(Reuters) - Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time in less than four months on ...
The latest update is out from Rumble ( (RUM)). Rumble Inc. has reported a strong third quarter in 2024, with a 39% increase in revenue to $25.1 million and a 26% rise in monthly active users to 67 ...
Nvidia Corporation's AI-driven growth continues, but a cyclical decline looms when the first infrastructure build-out peaks.
During Q3, Urban One's radio division stood out as a bright spot amid broader challenges as the company reported a lowered ...
Shopify reported 26% revenue growth in Q3, reaching $2.16 billion, beating estimates and marking its sixth consecutive ...
Sea Limited beat expectations in Q3, showcasing notable growth on top and bottom lines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback